Latest filing published 18 Oct 2023 for Evolus, Inc., €12.0M.
Filing timeline
BuySaleInsider track record
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Medytox Inc.: trading record in brief
This profile gathers the share dealings of Medytox Inc. in Evolus, Inc. The record holds 25 filings, for trades running from 11 August 2021 to 16 October 2023.
Both buying and selling appear: 15 purchases worth €6.9M, against 10 sales worth €31.8M. The net balance comes to €25.0M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings 2 purchases and 3 sales.
The median purchase comes to €465k. None of the 13 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 18 October 2023, the filings show an open-market sale worth €12.0M in Evolus, Inc. The latest purchase dates back some time: it was published 1,372 days ago, on 6 February 2023. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Medytox Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,690,663 shares@ US$7.5031.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-23-012379:0
- 2,187,511 shares@ US$8.5045.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-23-001621:0
- 23,000 shares@ US$10.99020.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-23-001468:0Canonical exit: 10 Nov 2021 (T+90)
- 38,304 shares@ US$8.99170.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-010336:0
- 6,848 shares@ US$8.950.2% of flowCommon Stock, $0.00001 par value per shareSEC:0001839882-22-023112:0
- 73,000 shares@ US$10.26952.0% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-009830:0
- 15,300 shares@ US$10.39080.4% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-009717:0
- 26,000 shares@ US$13.28310.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-008344:0
- 51,000 shares@ US$10.93271.4% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-009158:0Canonical exit: 25 Nov 2021 (T+90)
- 44,000 shares@ US$11.12241.2% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-009024:0Canonical exit: 23 Nov 2021 (T+90)
- 69,781 shares@ US$11.03131.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008933:0Canonical exit: 21 Nov 2021 (T+90)
- 55,000 shares@ US$10.51111.4% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008879:0Canonical exit: 17 Nov 2021 (T+90)
- 70,000 shares@ US$10.68661.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008746:0Canonical exit: 15 Nov 2021 (T+90)
- 49,714 shares@ US$10.97711.4% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008661:0Canonical exit: 11 Nov 2021 (T+90)
- 26,160 shares@ US$10.76980.7% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008519:0Canonical exit: 9 Nov 2021 (T+90)
15 of 15 declarations
